latest news releases from the newsroom
Amersham moves into Chinese Radiopharmaceuticals market through formation of Joint Venture
BUCKINGHAMSHIRE, U.K., Feb. 24, 2004 (PRIMEZONE) -- Amersham (LSE, NYSE, OSE: AHM), a leader in medical diagnostics and in life sciences, today announced plans to enter the Chinese radiopharmaceuticals market through the formation of a joint venture, Amersham Kexing Pharmaceuticals Co., Ltd.Amersham is investing in the joint venture with its Japanese affiliate, Nihon-Medi Physics Co. Ltd, (NMP) and two Chinese partners, China Xinxing Corporation (Group) and the Shanghai Nuclear Technique Development Corporation. Amersham and NMP will together hold a 70% stake in the venture through a joint holding company. Financial details of the investment were not disclosed.
Bure increases its ownership and influence in Carl Bro
GOTHENBURG, Sweden, Feb. 24, 2004 (PRIMEZONE) -- The Board of Directors of Carl Bro has decided to implement a new share issue for DKK 75M, with a right of preference for the company's shareholders, subject to the approval by an Extraordinary General Meeting. Bure has also acquired an additional 4 per cent of the shares in Carl Bro.
Invitation to Attend the Annual General Meeting of Tripep AB
HUDDINGE, Sweden, Feb. 24, 2004 (PRIMEZONE) -- The Annual General Meeting of Tripep AB will be held on 25 March 2004 at 6 p.m. at the Kilsalen Room, Berns Conference Facility, Berzelii Park, Stockholm, Sweden. In addition to the customary issues, the Annual General Meeting will consider the Board of Directors' proposal for parallel listing of the company's shares on the London Stock Exchange AIM (Alternative Investment Market), proposals on authorisation for the Board to resolve on the new issue of shares and the sale of previously re-purchased shares, and the election of a Nomination Committee. The Invitation to Attend is attached to this press release and will be published in Swedish national daily newspaper Svenska Dagbladet and the Swedish Official Gazette on 26 February 2004.